CVS Health Corporation CVS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 154.64% | 191.77% | 65.43% | 79.01% | -4,668.97% |
| Total Depreciation and Amortization | -0.18% | -3.84% | -3.38% | 0.00% | -2.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.77% | 200.00% | -3.57% | 159.78% | 1,249.22% |
| Change in Net Operating Assets | 186.31% | 811.33% | -99.86% | -159.14% | 33.96% |
| Cash from Operations | 493.47% | 234.48% | -6.74% | 82.26% | 206.85% |
| Capital Expenditure | -17.05% | -13.84% | -14.27% | -2.08% | -4.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 97.93% | 96.64% | 75.00% | 30.00% | -2,316.67% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -78.71% | -298.99% | -2,100.00% | -622.51% | 58.76% |
| Cash from Investing | -33.54% | -83.98% | -14.70% | -265.27% | 37.65% |
| Total Debt Issued | -- | -- | -- | -100.00% | 408.00% |
| Total Debt Repaid | 79.30% | -310.60% | 5.24% | 58.69% | -153.17% |
| Issuance of Common Stock | 4.27% | 142.55% | -28.47% | 352.63% | 2.63% |
| Repurchase of Common Stock | -5.00% | -27.19% | 18.18% | -225.00% | -400.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.83% | -1.39% | -0.83% | -0.84% | -1.08% |
| Other Financing Activities | -110.53% | 31.82% | -104.35% | -85.42% | 375.00% |
| Cash from Financing | -10.42% | -434.12% | 0.60% | -571.46% | 12.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.38% | 5.30% | -27.70% | -136.70% | 52.94% |